LOS ANGELES CAPITAL MANAGEMENT LLC

Holdings History for Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (APLS)

Symbol: APLS on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.07%	+0.02%	$19,729,074	951,716	+330,926	+53%	$20.73	Q4 2025
30 Sep 2025	0.05%	+0.05%	$14,048,478	620,790	+620,790	NEW	$22.63	Q3 2025
30 Sep 2023		-0%	$0	0	-3,701	-100%	$22.05	Q3 2023
30 Jun 2023	0%	+0%	$337,161	3,701	+3,701	NEW	$91.10	Q2 2023
31 Dec 2022		-0%	$0	0	-4,314	-100%	$22.05	Q4 2022
30 Sep 2022	0%	+0%	$295,000	4,314	+4,314	NEW	$68.38	Q3 2022
30 Jun 2021		-0%	$0	0	-13,611	-100%	$22.05	Q2 2021
31 Mar 2021	0%	+0%	$584,000	13,611	+4,806	+55%	$42.91	Q1 2021
31 Dec 2020	0%	+0%	$504,000	8,805	+365	+4.3%	$57.24	Q4 2020
30 Sep 2020	0%	+0%	$255,000	8,440	+8,440	NEW	$30.21	Q3 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.